Deciphera’s Qinlock Hits GIST Roadblock With Phase III Failure

 
• By Alaric DeArment
  
Cancer cells on scientific background.3d illustration
Deciphera reported that the Phase III trial of Qinlock in second-line GIST did not reach its primary endpoint • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category